Contineum Therapeutics
CTNM
#7708
Rank
A$0.53 B
Marketcap
A$18.50
Share price
10.96%
Change (1 day)
-18.34%
Change (1 year)

Contineum Therapeutics (CTNM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$15.67 Million

According to Contineum Therapeutics's latest financial reports the company's total liabilities are A$15.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Contineum Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$23.76 M-91.84%
2023-12-31A$0.29 B37.71%
2022-12-31A$0.21 B8.37%
2021-12-31A$0.19 B